These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 15947113)
1. Enhanced protein kinase B/Akt signalling in pituitary tumours. Musat M; Korbonits M; Kola B; Borboli N; Hanson MR; Nanzer AM; Grigson J; Jordan S; Morris DG; Gueorguiev M; Coculescu M; Basu S; Grossman AB Endocr Relat Cancer; 2005 Jun; 12(2):423-33. PubMed ID: 15947113 [TBL] [Abstract][Full Text] [Related]
2. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells. St-Germain ME; Gagnon V; Mathieu I; Parent S; Asselin E Int J Oncol; 2004 May; 24(5):1311-24. PubMed ID: 15067356 [TBL] [Abstract][Full Text] [Related]
3. Role of the phosphatidylinositol 3-kinase/Akt and mTOR/P70S6-kinase pathways in the proliferation and apoptosis in multiple myeloma. Pene F; Claessens YE; Muller O; Viguié F; Mayeux P; Dreyfus F; Lacombe C; Bouscary D Oncogene; 2002 Sep; 21(43):6587-97. PubMed ID: 12242656 [TBL] [Abstract][Full Text] [Related]
4. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas. Kurose K; Zhou XP; Araki T; Cannistra SA; Maher ER; Eng C Am J Pathol; 2001 Jun; 158(6):2097-106. PubMed ID: 11395387 [TBL] [Abstract][Full Text] [Related]
5. Vitamin D arrests thyroid carcinoma cell growth and induces p27 dephosphorylation and accumulation through PTEN/akt-dependent and -independent pathways. Liu W; Asa SL; Fantus IG; Walfish PG; Ezzat S Am J Pathol; 2002 Feb; 160(2):511-9. PubMed ID: 11839571 [TBL] [Abstract][Full Text] [Related]
7. [PTEN expression in endometrial cancer and the prognosis]. Kanamori Y; Uegaki K; Kigawa J; Terakawa N Nihon Rinsho; 2004 Oct; 62 Suppl 10():406-9. PubMed ID: 15535277 [No Abstract] [Full Text] [Related]
8. PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization. Shin I; Yakes FM; Rojo F; Shin NY; Bakin AV; Baselga J; Arteaga CL Nat Med; 2002 Oct; 8(10):1145-52. PubMed ID: 12244301 [TBL] [Abstract][Full Text] [Related]
9. Dysregulation of PTEN and protein kinase B is associated with glioma histology and patient survival. Ermoian RP; Furniss CS; Lamborn KR; Basila D; Berger MS; Gottschalk AR; Nicholas MK; Stokoe D; Haas-Kogan DA Clin Cancer Res; 2002 May; 8(5):1100-6. PubMed ID: 12006525 [TBL] [Abstract][Full Text] [Related]
10. Alteration of PTEN expression in endometrial carcinoma is associated with down-regulation of cyclin-dependent kinase inhibitor, p27. An HJ; Lee YH; Cho NH; Shim JY; Kim JY; Lee C; Kim SJ Histopathology; 2002 Nov; 41(5):437-45. PubMed ID: 12405911 [TBL] [Abstract][Full Text] [Related]
11. PAkt, cyclin D1 and p27/Kip.1 in glioblastomas with and without EGFR amplification and PTEN mutation. Fiano V; Ghimenti C; Imarisio S; Silengo L; Schiffer D Anticancer Res; 2004; 24(5A):2643-7. PubMed ID: 15517868 [TBL] [Abstract][Full Text] [Related]
12. Vitamin D and its analog EB1089 induce p27 accumulation and diminish association of p27 with Skp2 independent of PTEN in pituitary corticotroph cells. Liu W; Asa SL; Ezzat S Brain Pathol; 2002 Oct; 12(4):412-9. PubMed ID: 12408227 [TBL] [Abstract][Full Text] [Related]
13. Nuclear PTEN-mediated growth suppression is independent of Akt down-regulation. Liu JL; Sheng X; Hortobagyi ZK; Mao Z; Gallick GE; Yung WK Mol Cell Biol; 2005 Jul; 25(14):6211-24. PubMed ID: 15988030 [TBL] [Abstract][Full Text] [Related]
14. PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells mediated by p27kip1. Bruni P; Boccia A; Baldassarre G; Trapasso F; Santoro M; Chiappetta G; Fusco A; Viglietto G Oncogene; 2000 Jun; 19(28):3146-55. PubMed ID: 10918569 [TBL] [Abstract][Full Text] [Related]
16. The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression. Cappellini A; Tabellini G; Zweyer M; Bortul R; Tazzari PL; Billi AM; Falà F; Cocco L; Martelli AM Leukemia; 2003 Nov; 17(11):2157-67. PubMed ID: 12931221 [TBL] [Abstract][Full Text] [Related]
17. PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein. Paramio JM; Navarro M; Segrelles C; Gómez-Casero E; Jorcano JL Oncogene; 1999 Dec; 18(52):7462-8. PubMed ID: 10602505 [TBL] [Abstract][Full Text] [Related]
18. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells. Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865 [TBL] [Abstract][Full Text] [Related]
19. Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol-3'-kinase/protein kinase B (Akt) signal transduction pathway in glioblastomas. Knobbe CB; Reifenberger G Brain Pathol; 2003 Oct; 13(4):507-18. PubMed ID: 14655756 [TBL] [Abstract][Full Text] [Related]
20. Complex regulation of the cyclin-dependent kinase inhibitor p27kip1 in thyroid cancer cells by the PI3K/AKT pathway: regulation of p27kip1 expression and localization. Motti ML; Califano D; Troncone G; De Marco C; Migliaccio I; Palmieri E; Pezzullo L; Palombini L; Fusco A; Viglietto G Am J Pathol; 2005 Mar; 166(3):737-49. PubMed ID: 15743786 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]